01 / 05
Austin to Allow Some Apartments to Have Only One Staircase

KVUE | Housing

Austin to Allow Some Apartments to Have Only One Staircase

“On Thursday [4/10/25], Austin City Council members approved a change to building codes that will soon allow apartments up to five stories tall to be built with only one staircase.

The change is set to begin on July 10, after a resolution to the city’s building technical codes was introduced in 2024. Councilmember José ‘Chito’ Vela said the units would include advanced sprinkler systems and protected stairwells.”

From KVUE.

US Food and Drug Administration | Health & Medical Care

A Drug to Treat the Full Range of Narcolepsy Type 1 Symptoms

“The U.S. Food and Drug Administration today approved Orzeyful (oveporexton) tablets for the treatment of narcolepsy type 1 in adults. Orzeyful is the first medicine approved for narcolepsy type 1 as a complete disorder — addressing the full range of symptoms that define the condition — and the first to work by directly targeting the loss of orexin signaling that causes the disease.”

From US Food and Drug Administration.

Zag Daily | Air Transport

DoorDash Launches Drone Airline After FAA Approval

“California-based delivery platform DoorDash has launched its own drone delivery business after securing regulatory approval to operate commercial drone services in the United States.

The company has received Federal Aviation Administration (FAA) Part 135 air carrier certification, allowing it to launch DoorDash Air, an in-house drone programme developed by its robotics division, DoorDash Labs. Alongside operating the service, DoorDash is also developing its own aircraft for local deliveries.

The approval makes DoorDash one of only a handful of drone operators in the US authorised to run commercial delivery services under its own certificate.”

From Zag Daily.

US Food and Drug Administration | Health Systems

FDA Licenses First-Ever Freeze-Dried Plasma Product in the US

“The U.S. Food and Drug Administration today licensed Ezplaz Freeze Dried Plasma (FDP), making it the first freeze-dried plasma product licensed for use in the United States. Ezplaz is intended for transfusion in adult patients who need plasma and for whom other plasma products are not available…

Unlike conventional plasma products that must be stored frozen and thawed before use, Ezplaz can be stored at room temperature, is stable after exposure to temperature fluctuations and is rapidly reconstituted. It is packaged in a plastic bag rather than a glass bottle, reducing the risk of breakage during handling and transport. FDA expects that these features will make the use of Ezplaz compatible with austere environments, potentially including combat zones, remote areas, and disaster response settings.”

From US Food and Drug Administration.